Jayanta Haldar
@jayanta-amr.bsky.social
13 followers
8 following
15 posts
Professor at JNCASR, Working on AMR, infection, antimicrobial therapeutics and biomaterials. Editor-in-Chief of ACS Infectious Diseases
Posts
Media
Videos
Starter Packs
Jayanta Haldar
@jayanta-amr.bsky.social
· Aug 26
World Sepsis Day 2025: Advancing Research and Awareness | ACS Publications Chemistry Blog
World Sepsis Day is a global initiative aimed at raising awareness of sepsis—a life-threatening condition caused by the body’s extreme response to infection. Read on for recent research, advances in t...
axial.acs.org
Jayanta Haldar
@jayanta-amr.bsky.social
· Jul 23
Combating Tuberculosis: Obstacles, Innovations, and the Road Ahead
Tuberculosis (TB) remains one of the world’s leading infectious diseases. Every year on March 24th, World Tuberculosis Day is observed, which in 1882 is when Robert Koch announced the discovery of Mycobacterium tuberculosis (Mtb) as the causative agent of TB. This Special Issue features 30 original research articles, perspectives, and reviews from researchers representing 11 countries across all six major continents. ACS Infectious Diseases hopes this special issue encourages our readers to explore the wide range of research showcasing advances in drug discovery and a greater understanding of TB biology.
shorturl.at
Jayanta Haldar
@jayanta-amr.bsky.social
· Jul 23
ACS Infectious Diseases
This study reports on the antiparasitic profiles of batzelladines F and L, which exhibited strong antiplasmodial activity, moderate cytotoxicity, and good selectivity indexes. Both compounds act quickly against resistant and clinical isolates of P. falciparum, with batzelladine F also showing in vivo activity in a P. berghei model. These findings support the development of guanidine alkaloid derivatives as promising candidates for malaria treatment. View the article.
pubs.acs.org
Jayanta Haldar
@jayanta-amr.bsky.social
· May 13